Drug intelligence / Profile preview

elaeagnus angustifolia extract

Development stage
Phase 3
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical, External, Peritoneal (animal Research)
01

Overview

Elaeagnus angustifolia extract is a botanical extract derived from the fruit, flowers, or leaves of the Elaeagnus angustifolia plant, commonly known as Russian olive or oleaster. It contains a variety of phytochemicals, particularly flavonoids, terpenoids, polyphenols, and the alkaloid elaeagnin. The extract is traditionally used in folk medicine for its analgesic, anti-inflammatory, antioxidant, antimicrobial, antinociceptive, muscle relaxant, and wound-healing properties. Its mechanisms of action include: inhibition of cyclooxygenase 1 and 2 (COX1 and COX2) enzymes, partial agonism at benzodiazepine receptors (likely via certain flavones), modulation of GABA_A receptors, antioxidant activity, and modulation of acetylcholine signaling in smooth muscle. There is evidence and traditional use for applications in pain management for osteoarthritis and rheumatoid arthritis, wound and ulcer healing, management of gastrointestinal disorders (such as peptic ulcers and colitis), central muscle relaxation, and neurological disorders including epilepsy. The extract is available in at least one branded form (pshatin) as a polyphenol-rich preparation, used as a therapeutic for colitis and gastrointestinal diseases. Clinical evidence for most uses is limited or consists of small trials, animal models, or traditional practice rather than large-scale randomized controlled studies[1][2].

Brand names
pshatin
Other names
oleaster extractRussian olive extractsenjed extract
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)AChR (Acetylcholine receptor)BZD site (GABA-A receptor benzodiazepine site)GABAA (Gamma-aminobutyric acid receptor)MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on elaeagnus angustifolia extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on elaeagnus angustifolia extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call